Department of Radiation Oncology, University of Freiburg, Germany.
Radiother Oncol. 2010 Sep;96(3):325-7. doi: 10.1016/j.radonc.2010.08.001. Epub 2010 Aug 20.
AA-PET (MET-PET and FET-PET) can be used for gross tumour volume (GTV) delineation in brain gliomas and for the differentiation between treatment-related changes (pseudo-progression, pseudo-regression) and residual/recurrent tumour. There are some data showing that MET-PET and (DOTATOC)-PET can be used for GTV delineation in meningiomas and glomus tumours. The role of PET in the visualization of the biological characteristics of the tumours: proliferation (FLT-PET), hypoxia (FMISO-PET) and angiogenesis/peptide expression (RGD-PET) should be investigated in future studies.
AA-PET（MET-PET 和 FET-PET）可用于脑胶质瘤的大体肿瘤体积（GTV）勾画，以及区分治疗相关变化（假性进展、假性缓解）和残留/复发肿瘤。有一些数据表明，MET-PET 和（DOTATOC）-PET 可用于脑膜瘤和神经鞘瘤的 GTV 勾画。在未来的研究中，应探讨 PET 在肿瘤生物学特征可视化方面的作用，如增殖（FLT-PET）、缺氧（FMISO-PET）和血管生成/肽表达（RGD-PET）。
